Please use this identifier to cite or link to this item:

Title: New models towards assessing anti-cancer therapeutics
Issue Date: 2012
Publisher: F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología
Citation: Histology and histopathology, Vol. 27, nº 2 (2012)
ISSN: 1699-5848
Related subjects: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Keywords: Cancer
Abstract: Cancer is the subject of intense research around the world, but many questions about how the disease works remain unanswered. How exactly does cancer start and how do tumours grow? In fact, at present there are ten times more anticancer drugs being tested in clinical trials than there were 15 years ago. However, many of the new anticancer agents are predicted to show clinical benefit in only small subpopulations of patients. The cancer stem cell model could explain not only how some cancers work but also why patients suffer relapses, providing a good opportunity to gain insight into the reasons why agents work or, more commonly, don’t work, before going into a clinical trial
Primary author: Romero Camarero, Isabel
Barajas Diego, Marcos
Castellanos Martín, Andrés
García Martín, Ángel
Varela, Gonzalo
Abad, Mar
Ludeña, María Dolores
Pérez Losada, Jesús
Sánchez García, Isidro
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 14
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.27, nº 2 (2012)

Files in This Item:
File Description SizeFormat 
Romero-Camarero-27-157-170-2012.pdf896,74 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons